Trinity Biotech ADR buy StockNews.com
Start price
05.03.23
/
50%
€0.95
Target price
05.03.24
-
Performance (%)
-55.37%
End price
06.03.24
-
Summary
This prediction is currently being closed. The BUY prediction by StockNews_com for Trinity Biotech ADR is performing very badly with a performance of -55.37%. StockNews_com has a follow-up prediction for Trinity Biotech ADR, but this time predicts that Trinity Biotech ADR is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Trinity Biotech ADR | - | - | - | - |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% | 45.717% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% | 73.262% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% | 48.769% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% | 55.803% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten